{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:35:12Z","timestamp":1787578512486,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"crossref","award":["NCI 1K08CA271949-01"],"award-info":[{"award-number":["NCI 1K08CA271949-01"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>This study aimed to evaluate maternal outcomes in a large cohort with high prevalence of human immunodeficiency virus (HIV) infection in Botswana after implementation of a treat-all policy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>In this retrospective cohort study, data were collected from the medical record at the time of discharge from November 2021 to December 2023. Outcomes were recorded in the Tsepamo Birth Outcomes Surveillance and Safe Birth studies at Princess Marina Hospital in Botswana. We evaluated maternal mortality and obstetric morbidities by HIV status, including preeclampsia, eclampsia, hemorrhage, infection, and acute pulmonary or cardiac conditions at the time of hospital discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      We included 11,754 participants; 2,201 (18.7%) were pregnant people with HIV infection. Ninety-seven percent (2,135) were on antiretroviral therapy (ART) at time of delivery; 1,996 (93.5%) of those with a known ART regimen were on dolutegravir, tenofovir disoproxil fumarate, and lamivudine. Of the 1,090 people with HIV infection with known CD4 counts, 757 (69.4%) had more than 500 cells\/microliter, and only 42 (3.9%) had fewer than 200 cells\/microliter. Of 1,524 people with HIV infection with known viral loads, 1,436 (94.2%) were undetectable on initial testing. There were no statistically significant differences in incidence of hemorrhage (90 [4.1%] vs 370 [3.9%], adjusted risk ratio [RR] 0.93, 95% CI, 0.73\u20131.17), infection (38 [1.7%] vs 126 [1.3%], adjusted RR 1.56, 95% CI, 0.97\u20132.51), eclampsia (6 [0.3%] vs 28 [0.3%], adjusted RR 1.12, 95% CI, 0.50\u20132.53), acute pulmonary or cardiac conditions (15 [0.7%] vs 43 [0.4%], adjusted RR 1.22, 95% CI, 0.65\u20132.27), transfusion of 2 or more units of packed red blood cells (33 [36.7%] vs 110 [29.8%],\n                      <jats:italic toggle=\"yes\">P=<\/jats:italic>\n                      .21), additional uterotonics (48 [53.3%] vs 173 [47.1%],\n                      <jats:italic toggle=\"yes\">P=<\/jats:italic>\n                      .29), use of tranexamic acid (31 [ 34.4%] vs 106 [29.0%],\n                      <jats:italic toggle=\"yes\">P=<\/jats:italic>\n                      .31), intensive care unit admission (4 [0.2%] vs 10 [0.1%],\n                      <jats:italic toggle=\"yes\">P=<\/jats:italic>\n                      .31), mechanical ventilation (3 [0.1%] vs 6 [0.1%],\n                      <jats:italic toggle=\"yes\">P=<\/jats:italic>\n                      .38), pressor support (2 [0.1%] vs 2 [0.0%],\n                      <jats:italic toggle=\"yes\">P=<\/jats:italic>\n                      .16), or mortality (5 [0.2%] vs 11 [0.1%], adjusted RR 1.44, 95% CI, 0.46\u20134.57) in people with HIV infection compared with those without HIV infection. There were few notable differences, including a slightly reduced risk of preeclampsia (184 [8.4%] vs 818 [8.6%], adjusted RR 0.84, 95% CI, 0.71\u20130.98) and, although rare, an increased risk of uterine rupture (12 [0.5%] vs 8 [0.1%], adjusted RR 6.54, 95% CI, 2.33\u201318.33) in people with HIV infection compared with those without HIV infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>There was little difference in adverse maternal obstetric outcomes between people with and those without HIV infection in the treat-all era with integrase strand inhibitors (primarily dolutegravir); notable exceptions included a slightly reduced risk of preeclampsia and, although rare, an increased risk of uterine rupture in those with HIV infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000006039","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T21:01:02Z","timestamp":1755810062000},"page":"860-867","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Adverse Maternal Outcomes Among People With Human Immunodeficiency Virus (HIV) Using Antiretroviral Therapy in Botswana"],"prefix":"10.1097","volume":"146","author":[{"given":"J. Sroda","family":"Agudogo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Jackson-Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annliz","family":"Macharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgette","family":"Wamakima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katlego","family":"Boikanyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modiegi","family":"Diseko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Mabuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercy","family":"Nassali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dudu","family":"Rubgega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira","family":"Ranaweera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Makhema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Modest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele R.","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Zash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Justus","family":"Hofmeyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger L.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Luckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"R1-20260824","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(13)60803-X","article-title":"Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV\/AIDS Data on Africa (ALPHA)","volume":"381","author":"Zaba","year":"2013","journal-title":"Lancet"},{"key":"R2-20260824","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijgo.2014.05.024","article-title":"HIV and maternal mortality","volume":"127","author":"Lathrop","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"R3-20260824","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/INF.0000000000004745","article-title":"Birth defects and adverse pregnancy outcomes in hospital-based birth surveillance in eswatini","volume":"44","author":"Gill","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"R4-20260824","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJMra2212877","article-title":"Antiretroviral therapy and adverse pregnancy outcomes in people living with HIV","volume":"388","author":"Eke","year":"2023","journal-title":"N Engl J Med"},{"key":"R5-20260824","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/INF.0000000000003174","article-title":"Adverse pregnancy outcomes among HIV-positive women in the era of universal antiretroviral therapy remain elevated compared with HIV-negative women","volume":"40","author":"Tukei","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R6-20260824","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/QAD.0b013e32835fd940","article-title":"The contribution of HIV to pregnancy-related mortality: a systematic review and meta-analysis","volume":"27","author":"Calvert","year":"2013","journal-title":"AIDS"},{"issue":"suppl 4","key":"R7-20260824","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1471-0528.12869","article-title":"The confidential enquiry into maternal deaths in South Africa: a case study","volume":"121","author":"Moodley","year":"2014","journal-title":"BJOG"},{"key":"R9-20260824","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1812281","article-title":"Universal testing, expanded treatment, and incidence of HIV infection in Botswana","volume":"381","author":"Makhema","year":"2019","journal-title":"N Engl J Med"},{"key":"R13-20260824","doi-asserted-by":"crossref","first-page":"e26008","DOI":"10.1002\/jia2.26008","article-title":"Incident HIV acquisition among pregnant women in Botswana: findings from the Tsepamo Birth Outcomes Surveillance Study","volume":"26","author":"Mussa","year":"2023","journal-title":"J Int AIDS Soc"},{"key":"R14-20260824","doi-asserted-by":"crossref","first-page":"e804","DOI":"10.1016\/S2214-109X(18)30218-3","article-title":"Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study","volume":"6","author":"Zash","year":"2018","journal-title":"Lancet Glob Health"},{"key":"R15-20260824","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jpids\/piaa051","article-title":"Adverse birth outcomes in Botswana among women with vertically or horizontally acquired human immunodeficiency virus","volume":"10","author":"Fennell","year":"2021","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R16-20260824","doi-asserted-by":"crossref","first-page":"e172222","DOI":"10.1001\/jamapediatrics.2017.2222","article-title":"Comparative safety of antiretroviral treatment regimens in pregnancy","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R17-20260824","doi-asserted-by":"crossref","first-page":"e25763","DOI":"10.1002\/jia2.25763","article-title":"Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana","volume":"24","author":"Zash","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"R18-20260824","doi-asserted-by":"crossref","first-page":"e31580","DOI":"10.1371\/journal.pone.0031580","article-title":"High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana","volume":"7","author":"Shapiro","year":"2012","journal-title":"PLoS One"},{"issue":"suppl 1","key":"R19-20260824","first-page":"S105","article-title":"HIV-infected women on antiretroviral treatment have increased mortality during pregnant and postpartum periods","volume":"27","author":"Matthews","year":"2006","journal-title":"AIDS"},{"key":"R20-20260824","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jri.2005.12.001","article-title":"Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women","volume":"70","author":"Fiore","year":"2006","journal-title":"J Reprod Immunol"},{"key":"R21-20260824","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00011-018-1190-3","article-title":"Pre-eclampsia: the role of highly active antiretroviral therapy and immune markers","volume":"68","author":"Phoswa","year":"2019","journal-title":"Inflamm Res"},{"key":"R22-20260824","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0140-6736(02)11195-0","article-title":"Pre-eclampsia, antiretroviral therapy, and immune reconstitution","volume":"360","author":"Wimalasundera","year":"2002","journal-title":"Lancet"},{"key":"R23-20260824","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/01.aids.0000210610.52836.07","article-title":"Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality","volume":"20","author":"Wyatt","year":"2006","journal-title":"AIDS"},{"key":"R24-20260824","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/aid.2016.0098","article-title":"Acute kidney injury, risk factors, and prognosis in hospitalized HIV-infected adults in South Africa, compared by tenofovir exposure","volume":"33","author":"Seedat","year":"2017","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R25-20260824","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1182\/blood-2010-07-298992","article-title":"Dysregulation of CD4+CD25+CD127lowFOXP3+ regulatory T cells in HIV-infected pregnant women","volume":"117","author":"Kolte","year":"2011","journal-title":"Blood"},{"key":"R26-20260824","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/pharmacy10060164","article-title":"Long-term evaluation of changes in kidney function after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients living with HIV","volume":"10","author":"Gilbert","year":"2022","journal-title":"Pharmacy"},{"key":"R27-20260824","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/QAI.0000000000002747","article-title":"Safety of tenofovir alafenamide in people with HIV who experienced proximal renal tubulopathy on tenofovir disoproxil fumarate","volume":"88","author":"Campbell","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R28-20260824","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/jod.jod_21_18","article-title":"HIV and antiretroviral therapy-induced metabolic syndrome in people living with HIV and its implications for care: a critical review","volume":"10","author":"Masuku","year":"2019","journal-title":"J Diabetol"},{"key":"R29-20260824","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/trf.13040","article-title":"The impact of human immunodeficiency virus infection on obstetric hemorrhage and blood transfusion in South Africa","volume":"55","author":"Bloch","year":"2015","journal-title":"Transfusion"},{"key":"R30-20260824","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7196\/SAMJ.2017.v107i7.11166","article-title":"An increase in rates of obstetric haemorrhage in a setting of high HIV seroprevalence","volume":"107","author":"Shabalala","year":"2017","journal-title":"S Afr Med J"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:13:19Z","timestamp":1787577199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000006039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000006039","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"2025-04-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}